Optimizing Nursing Communication for Symptom Management in Hemodialysis: Development of an Artificial Intelligence-Based Web Predictive Model for Burden Classification and Evidence Navigation.
Source check: Source checked. Not independent scientific confirmation.
Finding: The open-access primary article develops and evaluates an AI symptom-burden classifier for 1,866 hemodialysis patients, with feature selection, eight model families, held-out testing, calibration, decision-curve analysis and SHAP interpretation. Published in Journal of Nursing Management.
Technology: Elastic net/Boruta selection and eight classifiers, including XGBoost, predict mild versus severe symptom burden.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Elastic net/Boruta selection and eight classifiers, including XGBoost, predict mild versus severe symptom burden.
- Test and result
- The 1,866-patient cohort used a 70/30 train-test split, cross-validation, calibration, DCA and subgroup analyses.
- Limitation / still unknown
- External replication and real-world or clinical benefit were not established by the reviewed study
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://onlinelibrary.wiley.com/doi/10.1155/jonm/4579091 · https://pubmed.ncbi.nlm.nih.gov/41199855/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.